Striving towards the elimination of HCV infection, Berlin 2018: Berlin, Germany, 2-3 February 2018
Striving towards the elimination of HCV infection, Berlin 2018

Striving towards the elimination of HCV infection, Berlin 2018

Berlin, Germany
2-3 February 2018

Description:
Globally, morbidity and mortality due to HCV infection continues to rise. However, the availability of simple and tolerable DAA therapies for HCV infection with cure rates >90% is one of the greatest medical advances in decades. This has brought considerable optimism to people working in HCV.

Url:

Booking: https://go.evvnt.com/147888-1

Price
EASL Member Early fee: EUR 300
EASL Member: EUR 450
Non Member Early fee: EUR 450
Non Member : EUR 550

Speakers: Prof. Francesco Negro, Dr. Alessio Aghemo, Prof. Jason Grebely

Time: 8:00 am - 4:30 pm

Category:Conferences | Science, Health and Medicine
 
Leave a Comment
Full Name:
E-mail Address:
Message:
 
 
 

Back